Skip to main content

Day: October 19, 2022

Mullen Continues Acquisition Path with Purchase of ELMS Assets Including Factory in Mishawaka, IN., Enabling EV Production for Retail and Commercial Vehicle Lines

Manufacturing Capability to Produce 50,000 Vehicles Per Year Mullen’s cash on hand and funding commitment of up to $240 million provides the company with access of up to $275 million to close acquisition and fund vehicle launches BREA, Calif., Oct. 19, 2022 (GLOBE NEWSWIRE) —  via InvestorWire — Mullen Automotive, Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, announces the US Bankruptcy Court approval on Oct. 13th, 2022 of its acquisition of electric vehicle company ELMS’s (Electric Last Mile Solutions) assets in an all cash purchase.  In the Chapter 7 approved transaction Mullen will acquire ELMS’s manufacturing plant, all inventory and intellectual property. Acquisition benefits include:The factory in Mishawaka, IN providing Mullen with the capability to produce up...

Continue reading

Mullen Continues Acquisition Path With Purchase of ELMS Assets Including Factory in Mishawaka, IN., Enabling EV Production for Retail and Commercial Vehicle Lines

Manufacturing Capability to Produce 50,000 Vehicles Per YearMullen’s Cash on Hand and Funding Commitment of up to $240 Million Provides the Company With Access of up to $275 Million to Close Acquisition and Fund VehicleBREA, CA , Oct. 19, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Mullen Automotive, Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, announces the US Bankruptcy Court approval on Oct. 13th, 2022 of its acquisition of electric vehicle company ELMS’s (Electric Last Mile Solutions) assets in an all cash purchase.  In the Chapter 7 approved transaction, Mullen will acquire ELMS’s manufacturing plant, all inventory and intellectual property. Acquisition benefits include:The factory in Mishawaka, IN, providing Mullen with the capability to produce up to 50,000...

Continue reading

Zoomcar, the World’s Largest Emerging Market Focused Car Sharing Platform, Announces $10 Million Financial Investment in Connection with the Merger with Innovative International Acquisition Corp. (NASDAQ: IOAC)

BANGALORE, India, Oct. 19, 2022 (GLOBE NEWSWIRE) — As previously announced last week, Zoomcar, Inc. (“Zoomcar”), the world’s largest emerging market focused car sharing platform, and Innovative International Acquisition Corp. (“Innovative”) (NASDAQ: IOAC), a publicly traded special purpose acquisition company, entered into a definitive merger agreement (the “Merger Agreement”) that will result in Zoomcar becoming a publicly listed company. The transaction values the combined company (the “Combined Company”) at an implied pro forma enterprise value of approximately $456 million. Upon closing, the Combined Company will be renamed Zoomcar Holdings, Inc. and expects to list its common stock on Nasdaq. $10 Million Investment By Ananda Trust Investment In addition and simultaneously with the execution of the Merger Agreement...

Continue reading

UniFirst Announces Financial Results for the Fourth Quarter and Full Fiscal Year of Fiscal 2022

WILMINGTON, Mass., Oct. 19, 2022 (GLOBE NEWSWIRE) — UniFirst Corporation (NYSE: UNF) (the “Company,” “UniFirst” or “we”) today reported results for its fourth quarter and full year ended August 27, 2022, as compared to the corresponding periods in the prior fiscal year: Q4 2022 Financial HighlightsConsolidated revenues for the fourth quarter increased 11.0% to $516.4 million. Operating income was $33.3 million, a decrease of 26.0%. The quarterly tax rate decreased to 21.3% compared to 22.0% in the prior year. Net income decreased to $26.2 million, or 24.4%. Diluted earnings per share decreased to $1.39 from $1.82 in the prior year, or 23.6%.The Company’s financial results for the fourth quarter of fiscal 2022 included $9.1 million of costs directly attributable to its CRM, ERP and branding initiatives (the “Key Initiatives”)....

Continue reading

Maravai LifeSciences Temporarily Reinstates Carl Hull as CEO Amidst Pending Noncompetition Litigation

Maravai LifeSciences and Recently-Appointed CEO Trey Martin Vigorously Defending Against Suit SAN DIEGO, Calif., Oct. 19, 2022 (GLOBE NEWSWIRE) — Executive Chairman and former CEO of Maravai LifeSciences, Inc. (NASDAQ: MRVI) Carl Hull, has been reinstated as CEO of the company on an interim basis. Three subsidiaries of Danaher Corporation, two of which previously employed recently-appointed Maravai CEO William “Trey” Martin, III, have filed a lawsuit against Martin and Maravai in the Delaware Court of Chancery alleging that Martin is in breach of a noncompetition agreement. On October 18, 2022, the Court issued a temporary restraining order against Martin prohibiting him from working for Maravai pending a preliminary injunction hearing that is expected to occur later this year.   “We have complete confidence in Trey and are appalled...

Continue reading

Saratoga Investment Corp. Announces Offering of Notes and BBB+ Investment Grade Rating from Egan-Jones Ratings Company

NEW YORK, NY, Oct. 19, 2022 (GLOBE NEWSWIRE) — Saratoga Investment Corp. (the “Company”) (NYSE: SAR) announced the commencement of a registered public offering of unsecured notes (the “Notes”).  The Company also announced that it has received an investment grade rating of “BBB+” from Egan-Jones Ratings Company, an independent, unaffiliated rating agency. Egan-Jones is a Nationally Recognized Statistical Rating Organization (NRSRO) and is recognized by the National Association of Insurance Commissioners (NAIC) as a Credit Rating Provider (CRP). Egan-Jones is also certified by the European Securities and Markets Authority (ESMA). The Notes are expected to be listed on the New York Stock Exchange and to trade thereon within 30 days of the original issue date under the trading symbol “SAJ”. Ladenburg Thalmann & Co. Inc. and Oppenheimer &...

Continue reading

Spero Therapeutics to Present Data at IDWeek 2022

CAMBRIDGE, Mass., Oct. 19, 2022 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR) bacterial infections, today announced data presentations for 7 abstracts accepted at the Infectious Disease Society of America (IDSA) IDWeek™ 2022, taking place from October 19 – 23, 2022 in Washington, DC. Spero-affiliated presentations will showcase clinical and nonclinical data for tebipenem HBr, Spero’s oral antibiotic investigational candidate in development for the treatment of adults with complicated urinary tract infection (cUTI), including pyelonephritis, along with health outcomes and epidemiologic data highlighting the potential...

Continue reading

StepStone Real Estate Adds Yasmine Uzmez as Managing Director, Business Development to Support its Growing Business

NEW YORK, Oct. 19, 2022 (GLOBE NEWSWIRE) — StepStone Real Estate (SRE), the real estate arm of private markets investment firm StepStone Group (Nasdaq: STEP), announced today that Yasmine Uzmez has joined the firm as a Managing Director on its business development team. Ms. Uzmez will be based in StepStone’s New York office. Ms. Uzmez has more than 18 years’ experience in real estate and has held senior positions at real estate private placement firms Park Madison Partners and Shelter Rock Capital Advisors. In 2016, she founded Oderoche, a real estate capital raising and advisory boutique. A dual citizen of Belgium and the US, and a native French speaker, Ms. Uzmez began her career at J.P. Morgan in Belgium and Gemini Consulting in Paris and later joined CBRE’s consulting group in New York. “I have known Yasmine professionally...

Continue reading

With 12.5% CAGR, Transcatheter Heart Valve Replacement Market Size worth USD 10.34 Billion in 2026

According to Fortune Business Insights, The global Transcatheter Heart Valve Replacement market size is anticipated to reach USD 10.34 billion by 2026, market value stood at USD 4.04 billion in 2018 and is expected to rise at a CAGR of 12.5% during the forecast period set between 2019 to 2026. Rising geriatric Population and Vulnerability to Cardiac Problems will Drive Market Pune, India, Oct. 19, 2022 (GLOBE NEWSWIRE) — The global Transcatheter Heart Valve Replacement market size is anticipated to reach USD 10.34 billion by 2026 on account of the increasing number of death cases caused due to cardiac medical conditions worldwide. THVR is a minimally invasive procedure for replacing a narrowed aortic valve which fails to function properly. Most of the THVR products are currently in their investigational stage. Fortune Business...

Continue reading

Multitude SE – Managers’ Transactions – Vella

Multitude SE – Managers’ Transactions – Vella ____________________________________________Person subject to the notification requirementName: Shaun VellaPosition: Other senior manager Issuer: Multitude SELEI: 74370078YLPFWHE33716Notification type: INITIAL NOTIFICATIONReference number: 20443/4/4____________________________________________ Transaction date: 2022-10-17Venue: XETRA – REGULIERTER MARKT (XETA)Instrument type: SHAREISIN: FI4000106299Nature of the transaction: ACQUISITION Transaction details(1): Volume: 1890 Unit price: 2.3802 EURAggregated transactions(1): Volume: 1890 Volume weighted average price: 2.3802 EUR

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.